Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
BMC Pharmacol Toxicol
; 23(1): 73, 2022 09 27.
Article
in En
| MEDLINE
| ID: mdl-36167636
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sertraline
/
Obsessive-Compulsive Disorder
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
Language:
En
Journal:
BMC Pharmacol Toxicol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: